These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25911527)

  • 1. Safety of new oral anticoagulants.
    Vaughan Sarrazin MS; Rose A
    BMJ; 2015 Apr; 350():h1679. PubMed ID: 25911527
    [No Abstract]   [Full Text] [Related]  

  • 2. Effective antidotes for new anticoagulants.
    Lythgoe M
    BMJ; 2015 May; 350():h2775. PubMed ID: 26014356
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulation therapy: Bleeding no worse with novel agents.
    Phillips R
    Nat Rev Cardiol; 2015 Jul; 12(7):381. PubMed ID: 25962977
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.
    Abraham NS; Singh S; Alexander GC; Heien H; Haas LR; Crown W; Shah ND
    BMJ; 2015 Apr; 350():h1857. PubMed ID: 25910928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis should not be subject to selectivity and imbalance.
    Lewis LS
    BMJ; 2015 Jun; 350():h3337. PubMed ID: 26108537
    [No Abstract]   [Full Text] [Related]  

  • 6. Neither dabigatran nor rivaroxaban were linked to increased GI bleeding compared with warfarin.
    Koretz RL
    Ann Intern Med; 2015 Sep; 163(6):JC13. PubMed ID: 26370028
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study.
    Chang HY; Zhou M; Tang W; Alexander GC; Singh S
    BMJ; 2015 Apr; 350():h1585. PubMed ID: 25911526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New oral anticoagulants for non-valvular atrial fibrillation--safety issues.
    Barry M
    Ir Med J; 2013 Mar; 106(3):69. PubMed ID: 23951972
    [No Abstract]   [Full Text] [Related]  

  • 9. Gastrointestinal bleeding with the new oral anticoagulants--defining the issues and the management strategies.
    Desai J; Kolb JM; Weitz JI; Aisenberg J
    Thromb Haemost; 2013 Aug; 110(2):205-12. PubMed ID: 23702623
    [No Abstract]   [Full Text] [Related]  

  • 10. Atrial fibrillation and anticoagulation management: a wake-up call to practitioners, patients, and policymakers.
    Fanikos J
    J Med Econ; 2013 Oct; 16(10):1190-2. PubMed ID: 23919663
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral anticoagulants: the move beyond warfarin.
    Frei J; Carroll VS
    J Neurosci Nurs; 2014 Oct; 46(5):253-5. PubMed ID: 25188682
    [No Abstract]   [Full Text] [Related]  

  • 12. [New oral anticoagulants - sunset for warfarin in therapy of atrial fibrillation].
    Koziński M; Obońska K; Kubica A; Navarese EP; Kubica J
    Kardiol Pol; 2012; 70(10):1053-60. PubMed ID: 23080100
    [No Abstract]   [Full Text] [Related]  

  • 13. Direct oral anticoagulants in atrial fibrillation.
    Noll G; Noll S; Hürlimann D
    Semin Hematol; 2014 Apr; 51(2):139-46. PubMed ID: 24861798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New oral anticoagulants and risks in ENT.
    Hollis S
    Clin Otolaryngol; 2013 Aug; 38(4):355-7. PubMed ID: 23957550
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.
    Armbruster HL; Lindsley JP; Moranville MP; Habibi M; Khurram IM; Spragg DD; Berger RD; Calkins H; Marine JE
    Ann Pharmacother; 2015 Mar; 49(3):278-84. PubMed ID: 25515868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.
    Berman JP; Halperin JL
    Hosp Pract (1995); 2013 Feb; 41(1):37-48. PubMed ID: 23466966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New anticoagulants--should we have a little bit of cold water in the blood?].
    Dyrkorn R; Roland PD
    Tidsskr Nor Laegeforen; 2013 Feb; 133(4):390-1. PubMed ID: 23423204
    [No Abstract]   [Full Text] [Related]  

  • 18. Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study.
    Banerjee A; Lane DA; Torp-Pedersen C; Lip GY
    Thromb Haemost; 2012 Mar; 107(3):584-9. PubMed ID: 22186961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.
    Assiri A; Al-Majzoub O; Kanaan AO; Donovan JL; Silva M
    Clin Ther; 2013 Jul; 35(7):967-984.e2. PubMed ID: 23870607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjusted indirect comparison of new oral anticoagulants for stroke prevention in atrial fibrillation.
    Testa L; Agnifili M; Latini RA; Mattioli R; Lanotte S; De Marco F; Oreglia J; Latib A; Pizzocri S; Laudisa ML; Brambilla N; Bedogni F
    QJM; 2012 Oct; 105(10):949-57. PubMed ID: 22771555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.